Aldehyde oxidase

From WikiMD's WELLNESSPEDIA

An enzyme involved in the metabolism of aldehydes and nitrogen-containing compounds


Diagram of Aldehyde Oxidase

Aldehyde oxidase is a molybdenum-containing enzyme that plays a crucial role in the metabolism of a wide range of endogenous and exogenous aldehydes and nitrogen-containing compounds. It is a member of the xanthine oxidase family of enzymes and is found in many tissues throughout the body, including the liver, lung, and kidney.

Structure[edit]

Aldehyde oxidase is a complex enzyme that contains a molybdenum cofactor, two iron-sulfur clusters, and a flavin adenine dinucleotide (FAD) moiety. The enzyme is a homodimer, meaning it consists of two identical subunits. Each subunit contains the necessary cofactors for catalytic activity.

Function[edit]

The primary function of aldehyde oxidase is to catalyze the oxidation of aldehydes to their corresponding carboxylic acids. This reaction involves the transfer of electrons from the aldehyde to molecular oxygen, producing the carboxylic acid and hydrogen peroxide as byproducts. Aldehyde oxidase also participates in the metabolism of various drugs and xenobiotics, contributing to their detoxification and elimination from the body.

Clinical Significance[edit]

Aldehyde oxidase is involved in the metabolism of several clinically important drugs, including antidepressants, antipsychotics, and antiparasitic agents. Variations in aldehyde oxidase activity can affect drug metabolism and lead to differences in drug efficacy and toxicity among individuals. Genetic polymorphisms in the gene encoding aldehyde oxidase can result in altered enzyme activity, impacting drug metabolism.

Related Enzymes[edit]

Aldehyde oxidase is closely related to other molybdenum-containing enzymes, such as xanthine oxidase and sulfite oxidase. These enzymes share structural similarities and have overlapping substrate specificities, although each enzyme has distinct physiological roles.

Research and Applications[edit]

Research on aldehyde oxidase has focused on its role in drug metabolism and its potential as a target for drug development. Inhibitors of aldehyde oxidase are being investigated for their ability to modulate drug metabolism and improve the pharmacokinetic properties of therapeutic agents.

Related pages[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.